TLR9 and systemic lupus erythematosus: Actually, lupus NK cells present a strong basal activation level and seem to be exhausted, as shown by both the high CD69 expression in medium and the moderate response (not reaching significance) to the TLR9 agonist, respectively, suggesting that NK cells have been pre-activated in vivo.